Trileptal 300 mg in 5 mL Oral Suspension
RxNorm 351992
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 351992 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Trileptal 300 mg in 5 mL Oral Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Oxcarbazepine 60 mg/ML Oral Suspension [Trileptal]
(Atom ID: 1550129)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
OXcarbazepine 60 mg/ML Oral Suspension [Trileptal]
(Atom ID: 3742059)
PSNPrescribable
Prescribable Name (PSN):
Trileptal 300 mg in 5 mL Oral Suspension
(Atom ID: 8705237)
SYPrescribable
Synonym (SY):
Trileptal 300 mg per 5 mL Oral Suspension
(Atom ID: 3042906)
SYPrescribable
Synonym (SY):
Trileptal 60 mg/ML Oral Suspension
(Atom ID: 1550131)
Patient Education
Oxcarbazepine
Oxcarbazepine (Trileptal) is used alone or in combination with other medications to control certain types of seizures in adults and children. Oxcarbazepine extended-release tablets (Oxtellar XR) are used in combination with other medications to control certain types of seizures in adults and children 6 years of age and older. Oxcarbazepine is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.
[Learn More]
* Please review the disclaimer below.